OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A systematic review and meta-analysis of the association between clozapine and norclozapine serum levels and peripheral adverse drug reactions
Madeleine S. A. Tan, Faraz Honarparvar, James R. Falconer, et al.
Psychopharmacology (2021) Vol. 238, Iss. 3, pp. 615-637
Closed Access | Times Cited: 42
Madeleine S. A. Tan, Faraz Honarparvar, James R. Falconer, et al.
Psychopharmacology (2021) Vol. 238, Iss. 3, pp. 615-637
Closed Access | Times Cited: 42
Showing 1-25 of 42 citing articles:
Optimising plasma clozapine levels to improve treatment response: an individual patient data meta-analysis and receiver operating characteristic curve analysis
Korinne Northwood, Ella Pearson, Urška Arnautovska, et al.
The British Journal of Psychiatry (2023) Vol. 222, Iss. 6, pp. 241-245
Open Access | Times Cited: 24
Korinne Northwood, Ella Pearson, Urška Arnautovska, et al.
The British Journal of Psychiatry (2023) Vol. 222, Iss. 6, pp. 241-245
Open Access | Times Cited: 24
Clozapine in treatment-resistant schizophrenia: Reflections from the Hallmark US clinical trial and beyond
John M. Kane, Georgios Schoretsanitis, José M. Rubio, et al.
Schizophrenia Research (2024) Vol. 268, pp. 9-13
Open Access | Times Cited: 9
John M. Kane, Georgios Schoretsanitis, José M. Rubio, et al.
Schizophrenia Research (2024) Vol. 268, pp. 9-13
Open Access | Times Cited: 9
Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: Focus on antipsychotics
X.M. Hart, Gerhard Gründer, Nicolas Ansermot, et al.
The World Journal of Biological Psychiatry (2024) Vol. 25, Iss. 9, pp. 451-536
Closed Access | Times Cited: 9
X.M. Hart, Gerhard Gründer, Nicolas Ansermot, et al.
The World Journal of Biological Psychiatry (2024) Vol. 25, Iss. 9, pp. 451-536
Closed Access | Times Cited: 9
Adverse Drug Reactions in Relation to Clozapine Plasma Levels: A Systematic Review
Μαρία Σκώκου, Eleni A. Karavia, Zoi Drakou, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 817-817
Open Access | Times Cited: 34
Μαρία Σκώκου, Eleni A. Karavia, Zoi Drakou, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 7, pp. 817-817
Open Access | Times Cited: 34
Second to none: rationale, timing, and clinical management of clozapine use in schizophrenia
Mishal Qubad, Robert A. Bittner
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 18
Mishal Qubad, Robert A. Bittner
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 18
Therapeutic drug monitoring of clozapine in adults with schizophrenia: a review of challenges and strategies
Espen Molden
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 10, pp. 1211-1221
Closed Access | Times Cited: 40
Espen Molden
Expert Opinion on Drug Metabolism & Toxicology (2021) Vol. 17, Iss. 10, pp. 1211-1221
Closed Access | Times Cited: 40
Clozapine levels as a predictor for therapeutic response: A systematic review and meta‐analysis
Dan Siskind, Meghna Sharma, Mrinal Pawar, et al.
Acta Psychiatrica Scandinavica (2021) Vol. 144, Iss. 5, pp. 422-432
Open Access | Times Cited: 39
Dan Siskind, Meghna Sharma, Mrinal Pawar, et al.
Acta Psychiatrica Scandinavica (2021) Vol. 144, Iss. 5, pp. 422-432
Open Access | Times Cited: 39
Clozapine resistant schizophrenia: Newer avenues of management
Subho Chakrabarti
World Journal of Psychiatry (2021) Vol. 11, Iss. 8, pp. 429-448
Open Access | Times Cited: 36
Subho Chakrabarti
World Journal of Psychiatry (2021) Vol. 11, Iss. 8, pp. 429-448
Open Access | Times Cited: 36
Exploring low clozapine C/D ratios, inverted clozapine-norclozapine ratios and undetectable concentrations as measures of non-adherence in clozapine patients
Can‐Jun Ruan, I. Cánovas Olmos, Carina Ricciardi, et al.
Schizophrenia Research (2023)
Closed Access | Times Cited: 15
Can‐Jun Ruan, I. Cánovas Olmos, Carina Ricciardi, et al.
Schizophrenia Research (2023)
Closed Access | Times Cited: 15
When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis
Mishal Qubad, Gabriele Dupont, Martina Hahn, et al.
CNS Drugs (2024) Vol. 38, Iss. 9, pp. 671-696
Open Access | Times Cited: 5
Mishal Qubad, Gabriele Dupont, Martina Hahn, et al.
CNS Drugs (2024) Vol. 38, Iss. 9, pp. 671-696
Open Access | Times Cited: 5
Treatment strategies for clozapine-induced nocturnal enuresis and urinary incontinence: a systematic review
Timothy Tanzer, Nicola Warren, Laura McMahon, et al.
CNS Spectrums (2022) Vol. 28, Iss. 2, pp. 133-144
Open Access | Times Cited: 19
Timothy Tanzer, Nicola Warren, Laura McMahon, et al.
CNS Spectrums (2022) Vol. 28, Iss. 2, pp. 133-144
Open Access | Times Cited: 19
Association Between Clozapine Plasma Concentrations and Treatment Response: A Systematic Review, Meta-analysis and Individual Participant Data Meta-analysis
Federica Tralongo, Céline Konecki, Catherine Féliu, et al.
Clinical Pharmacokinetics (2023) Vol. 62, Iss. 6, pp. 807-818
Closed Access | Times Cited: 13
Federica Tralongo, Céline Konecki, Catherine Féliu, et al.
Clinical Pharmacokinetics (2023) Vol. 62, Iss. 6, pp. 807-818
Closed Access | Times Cited: 13
Therapeutic monitoring of plasma clozapine andN-desmethylclozapine (norclozapine): practical considerations
Robert J. Flanagan, Siobhan Gee, Sarah L. Belsey, et al.
BJPsych Advances (2023) Vol. 29, Iss. 2, pp. 92-102
Open Access | Times Cited: 12
Robert J. Flanagan, Siobhan Gee, Sarah L. Belsey, et al.
BJPsych Advances (2023) Vol. 29, Iss. 2, pp. 92-102
Open Access | Times Cited: 12
Respiratory aspiration during treatment with clozapine and other antipsychotics: a literature search and a pharmacovigilance study in vigibase
Carlos De las Cuevas, Emílio J. Sanz, Alejandro Villasante‐Tezanos, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 2, pp. 57-74
Open Access | Times Cited: 11
Carlos De las Cuevas, Emílio J. Sanz, Alejandro Villasante‐Tezanos, et al.
Expert Opinion on Drug Metabolism & Toxicology (2023) Vol. 19, Iss. 2, pp. 57-74
Open Access | Times Cited: 11
Clozapine treatment and astrocyte activity in treatment resistant schizophrenia: A proton magnetic resonance spectroscopy study
Edgardo Torres‐Carmona, Ali Abdolizadeh, Yusuke Iwata, et al.
Schizophrenia Research (2024) Vol. 270, pp. 152-161
Closed Access | Times Cited: 4
Edgardo Torres‐Carmona, Ali Abdolizadeh, Yusuke Iwata, et al.
Schizophrenia Research (2024) Vol. 270, pp. 152-161
Closed Access | Times Cited: 4
Effect of Valproic Acid on the Metabolic Spectrum of Clozapine in Patients With Schizophrenia
Robert L. Smith, Birgit M. Wollmann, Lennart Kyllesø, et al.
Journal of Clinical Psychopharmacology (2021) Vol. 42, Iss. 1, pp. 43-50
Closed Access | Times Cited: 25
Robert L. Smith, Birgit M. Wollmann, Lennart Kyllesø, et al.
Journal of Clinical Psychopharmacology (2021) Vol. 42, Iss. 1, pp. 43-50
Closed Access | Times Cited: 25
Therapeutic drug monitoring of clozapine in human serum by high-throughput paper spray mass spectrometry
Armin Saatchi, Taelor M. Zarkovic, Scott A. Borden, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab (2024) Vol. 32, pp. 41-46
Open Access | Times Cited: 3
Armin Saatchi, Taelor M. Zarkovic, Scott A. Borden, et al.
Journal of Mass Spectrometry and Advances in the Clinical Lab (2024) Vol. 32, pp. 41-46
Open Access | Times Cited: 3
The Impact of Therapeutic Drug Monitoring on Clozapine Dosing and Clinical Outcome in a Tertiary Care Center in India
Lakshmi Jogi, P Praveen, Aromal Shibu, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Lakshmi Jogi, P Praveen, Aromal Shibu, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
José de León, Ross J. Baldessarini, Richard Balon, et al.
Journal of Clinical Psychopharmacology (2025)
Closed Access
Therapeutic Reference Range for Clozapine Plasma Levels in Parkinson’s Disease or Dementia: A Systematic Review and Individual Participant Data Meta-analysis
Nazar Kuzo, Marianna Piras, Ulrich Lutz, et al.
Pharmacopsychiatry (2025)
Closed Access
Nazar Kuzo, Marianna Piras, Ulrich Lutz, et al.
Pharmacopsychiatry (2025)
Closed Access
Clozapine Worsens Glucose Intolerance, Nonalcoholic Fatty Liver Disease, Kidney Damage, and Retinal Injury and Increases Renal Reactive Oxygen Species Production and Chromium Loss in Obese Mice
Geng‐Ruei Chang, Hsien-Yueh Liu, Wei‐Cheng Yang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6680-6680
Open Access | Times Cited: 20
Geng‐Ruei Chang, Hsien-Yueh Liu, Wei‐Cheng Yang, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6680-6680
Open Access | Times Cited: 20
Treatment strategies for clozapine-induced hypotension: a systematic review
Timothy Tanzer, Thomas Brouard, Samuel E. Dal Pra, et al.
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 14
Timothy Tanzer, Thomas Brouard, Samuel E. Dal Pra, et al.
Therapeutic Advances in Psychopharmacology (2022) Vol. 12
Open Access | Times Cited: 14
Clozapine once- versus multiple-daily dosing: a two-center cross-sectional study, systematic review and meta-analysis
Nazar Kuzo, Ekkehard Haen, Dominic M. Ho, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 273, Iss. 7, pp. 1567-1578
Open Access | Times Cited: 14
Nazar Kuzo, Ekkehard Haen, Dominic M. Ho, et al.
European Archives of Psychiatry and Clinical Neuroscience (2022) Vol. 273, Iss. 7, pp. 1567-1578
Open Access | Times Cited: 14
Clozapine-related tachycardia: A conundrum to identify and treat
D. Brennan, Sweta Lal, Frans Hugo, et al.
Australasian Psychiatry (2024) Vol. 32, Iss. 1, pp. 84-88
Open Access | Times Cited: 2
D. Brennan, Sweta Lal, Frans Hugo, et al.
Australasian Psychiatry (2024) Vol. 32, Iss. 1, pp. 84-88
Open Access | Times Cited: 2
Clozapine-Encapsulated Binary Mixed Micelles in Thermosensitive Sol–Gels for Intranasal Administration
Madeleine S. A. Tan, Preeti Pandey, James R. Falconer, et al.
Gels (2022) Vol. 8, Iss. 1, pp. 38-38
Open Access | Times Cited: 10
Madeleine S. A. Tan, Preeti Pandey, James R. Falconer, et al.
Gels (2022) Vol. 8, Iss. 1, pp. 38-38
Open Access | Times Cited: 10
